QA: Anaptysbio INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001370053_2023_Anaptysbio_INC.pdf

Logs

Graph

Absolute values for 0001370053, Anaptysbio INC

  xvar xval
0 AssetsCurrent 447,205,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,089,000
3 remainder_Assets 161,089,000
4 LiabilitiesCurrent 26,054,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 75,388,961
9 ResearchAndDevelopmentExpense 87,248,584
10 remainder_Expenses 23,392
11 remainder_Revenues 10,627,369
12 remainder_NetIncome -35,757,218
13 remainder_ComprehensiveNetIncome -4,934,923
  yvar yval
0 Assets 610,383,000
1 Liabilities 26,054,000
2 Expenses 162,660,937
3 Revenues 10,627,369
4 StockholdersEquity 584,329,000
5 NetIncome -187,790,786
6 ComprehensiveNetIncome -190,258,248
7 BaseVar 425,208,724
8 EconomicCapitalRatiobeforeLimitedLiability 3.41
9 EconomicCapitalRatio 3.96

Edgar->Model Mapping

Feature Distribution

Change over Time